ARCHIVES

Komen Under Pressure: Charity Faces Money Woes, Attacks from Right

This article is from The Cancer Letter archive.

Vol. 38 No. 40 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

June 14, 2013

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005

National Cancer Policy Board a Successful Experiment, NCI Says; Funding Extended

May 19, 2000

NCI Seeks To Fund More Cancer Centers, Provide 2% Inflationary Increase For Grants

February 5, 2010

In Brief: Lawsuit Developing Over NCI X-Ray Contract; Califano May attempt To Trim NCI Authority

August 19, 1977

NiH Conference: More Discord Than Consensus At Statement’s Presentation

January 31, 1997